Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer.
Jeitany M, Leroy C, Tosti P, Lafitte M, Le Guet J, Simon V, Bonenfant D, Robert B, Grillet F, Mollevi C, El Messaoudi S, Otandault A, Canterel-Thouennon L, Busson M, Thierry AR, Martineau P, Pannequin J, Roche S, Sirvent A.
Jeitany M, et al. Among authors: sirvent a.
EMBO Mol Med. 2018 Apr;10(4):e7918. doi: 10.15252/emmm.201707918.
EMBO Mol Med. 2018.
PMID: 29438985
Free PMC article.